Report cover image

U.S. Periodontal Treatment for Adults Market

Published Feb 01, 2025
Length 350 Pages
SKU # DAABD20400627

Description

U.S. periodontal treatment for adults market is expected to reach USD 1,620.76 million by 2032 from USD 816.11 million in 2024, growing at a CAGR of 9.0% in the forecast period of 2025 to 2032.
Market Segmentation:
U.S. Periodontal Treatment For Adults Market, By Product Type (Regenerative Biomaterials and Antibiotics and Antimicrobials), Disease Type (Chronic Periodontitis, Gingivitis, Aggressive Periodontitis, Necrotizing Periodontal Diseases, AND Others), Practice Type (Private Practice and DSO (Dental Service Organizations)) - Industry Trends & Forecast To 2032

Overview of Vietnam elderly care market Dynamics:

Driver

• Expansion of Dental Insurance Coverage for Periodontal Care
Restrain

• High Treatment Costs Limiting Access to Periodontal Care for Adults

Opportunity

• Complexity of Treatment Protocols Increasing Challenges in Periodontal Care

Market Players:

The key market players operating in the U.S. periodontal treatment for adults market are listed below:

• Dentsply Siroma
• Straumann AG
• Medtronic
• OraPharma
• GSK.
• Life Net Health
• Pfizer
• Hioseen
• Osteogenics Biomedical
• Epien
• BioHorizons
• Biolase
• Biocomposites
• Biocare Services
• ZimVie
• Forward science
• PerioProtect

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

Table of Contents

350 Pages
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of The U.S. Periodontal Treatment For Adults Market
1.4 Currency And Pricing
1.5 Limitations
1.6 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Dbmr Tripod Data Validation Model
2.3 Primary Interviews With Key Opinion Leaders
2.4 Dbmr Market Position Grid
2.5 Vendor Share Analysis
2.6 Secondary Sources
2.7 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Porter’s Five Forces
4.2 Pestel Analysis
5 U.S. Periodontal Treatment For Adults Market: Regulations
5.1 Regulatory Authorities In The U.S.
6 Market Overview
6.1 Drivers
6.1.1 Expansion Of Dental Insurance Coverage For Periodontal Care
6.1.2 Improved Patient Education On The Importance Of Periodontal Health And Care
6.1.3 Connection Between Oral Health And Systemic Diseases Impacting Overall Health
6.2 Restraints
6.2.1 High Treatment Costs Limiting Access To Periodontal Care For Adults
6.2.2 Complexity Of Treatment Protocols Increasing Challenges In Periodontal Care
6.3 Opportunities
6.3.1 Emerging Treatments For Complex Periodontal Disease
6.3.2 Increasing Importance Of Periodontal Care
6.3.3 Growing Adoption Of Ai And Machine Learning In Periodontal Diagnostics
6.4 Challenges
6.4.1 Limited Awareness Of The Periodontal Treatments
6.4.2 Shortage Of Qualified Periodontal Specialists
7 U.S. Periodontal Treatment For Adults Market, By Product Type
7.1 Overview
7.2 Regenerative Biomaterials
7.2.1 Bone Grafts
7.2.2 Membranes For Guided Bone/Tissue Regeneration (Gbr/Gtr)
7.3 Antibiotics And Antimicrobials
8 U.S. Periodontal Treatment For Adults Market, By Practice Type
8.1 Overview
8.2 Private Practice
8.2.1 Regenerative Biomaterials
8.2.1.1 Bone Grafts
8.2.1.1.1 Allograft
8.2.1.1.2 Xenograft
8.2.1.1.3 Synthetic Bone Grafts
8.2.1.2 Membranes For Guided Bone/Tissue Regeneration (Gbr/Gtr)
8.2.1.2.1 Resorbable Membranes
8.2.1.2.2 Non-resorbable Membranes
8.3 Antibiotics And Antimicrobials
8.3.1 Local Antibiotic
8.3.2 Systemic Antibiotic Therapy
8.3.2.1 Oral Antibiotics
8.3.2.1.1 Doxycycline
8.3.2.1.2 Amoxicillin
8.3.2.1.3 Metronidazole
8.3.2.1.4 Clindamycin
8.3.2.1.5 Azithromycin
8.3.2.1.6 Vibramycin
8.3.2.1.7 Others
8.3.2.2 Topical Antibiotics
8.3.2.2.1 Minocycline Hydrochloride (Arestin)
8.3.2.2.2 Chlorhexidine
8.3.2.2.3 Doxycycline
8.3.2.2.4 Metronidazole Gel
8.3.2.2.5 Others
8.4 Dso (Dental Service Organizations)
8.4.1 Regenerative Biomaterials
8.4.1.1 Bone Grafts
8.4.1.1.1 Allograft
8.4.1.1.2 Xenograft
8.4.1.1.3 Synthetic Bone Grafts
8.4.1.2 Membranes For Guided Bone/Tissue Regeneration (Gbr/Gtr)
8.4.1.2.1 Resorbable Membranes
8.4.1.2.2 Non-resorbable Membranes
8.4.2 Antibiotics And Antimicrobials
8.4.2.1 Local Antibiotic
8.4.2.2 Systemic Antibiotic Therapy
8.4.2.2.1 Oral Antibiotics
8.4.2.2.1.1 Doxycycline
8.4.2.2.1.2 Amoxicillin
8.4.2.2.1.3 Metronidazole
8.4.2.2.1.4 Clindamycin
8.4.2.2.1.5 Azithromycin
8.4.2.2.1.6 Vibramycin
8.4.2.2.1.7 Others
8.4.2.2.2 Topical Antibiotics
8.4.2.2.2.1 Minocycline Hydrochloride (Arestin)
8.4.2.2.2.2 Chlorhexidine
8.4.2.2.2.3 Doxycycline
8.4.2.2.2.4 Metronidazole Gel
8.4.2.2.2.5 Others
9 U.S. Periodontal Treatment For Adults Market, By Disease Type
9.1 Overview
9.2 Chronic Periodontitis
9.3 Gingivitis
9.4 Aggressive Periodontitis
9.5 Necrotizing Periodontal Diseases
9.6 Others
10 Company Share Analysis: U.S.
11 Swot Analysis
12 Company Profiles
12.1 Dentsply Sirona
12.1.1 Company Snapshot
12.1.2 Revenue Analysis
12.1.3 Product Portfolio
12.1.4 Recent Developments
12.2 Institut Straumann Ag
12.2.1 Company Snapshot
12.2.2 Revenue Analysis
12.2.3 Product Portfolio
12.2.4 Recent Developments
12.3 Medtronic
12.3.1 Company Snapshot
12.3.2 Revenue Analysis
12.3.3 Product Portfolio
12.3.4 Recent Development
12.4 Orapharma
12.4.1 Company Snapshot
12.4.2 Product Portfolio
12.4.3 Recent Development
12.5 Gsk Plc.
12.5.1 Company Snapshot
12.5.2 Revenue Analysis
12.5.3 Product Portfolio
12.5.4 Recent Development
12.6 Biohorizons
12.6.1 Company Snapshot
12.6.2 Product Portfolio
12.6.3 Recent Development
12.7 Biolase Inc.
12.7.1 Company Snapshot
12.7.2 Revenue Analysis
12.7.3 Product Portfolio
12.7.4 Recent Development
12.8 Biocomposites
12.8.1 Company Snapshot
12.8.2 Product Portfolio
12.8.3 Recent Development
12.9 Epien Medical, Inc.
12.9.1 Company Snapshot
12.9.2 Product Portfolio
12.9.3 Recent Development
12.10 Forward Science
12.10.1 Company Snapshot
12.10.2 Product Portfolio
12.10.3 Recent Development
12.11 Hiossen
12.11.1 Company Snapshot
12.11.2 Product Portfolio
12.11.3 Recent Development
12.12 Lifenet Health
12.12.1 Company Snapshot
12.12.2 Product Portfolio
12.12.3 Recent Development
12.13 Nobel Biocare Usa
12.13.1 Company Snapshot
12.13.2 Product Portfolio
12.13.3 Recent Development
12.14 Osteogenics Biomedical
12.14.1 Company Snapshot
12.14.2 Product Portfolio
12.14.3 Recent Development
12.15 Perio Protect
12.15.1 Company Snapshot
12.15.2 Product Portfolio
12.15.3 Recent Development
12.16 Pfizer
12.16.1 Company Snapshot
12.16.2 Revenue Analysis
12.16.3 Product Portfolio
12.16.4 Recent Development
12.17 Zimvie Inc.
12.17.1 Company Snapshot
12.17.2 Revenue Analysis
12.17.3 Product Portfolio
12.17.4 Recent Development
13 Questionnaire
14 Related Reports
List Of Tables
Table 1 U.S. Periodontal Treatment For Adults Market, By Product Type, 2018-2032 (Usd Million)
Table 2 U.S. Regenerative Biomaterials In Periodontal Treatment For Adults Market, By Product Type 2018-2032 (Usd Million)
Table 3 U.S. Bone Grafts In Periodontal Treatment For Adults Market, By Product Type, 2018-2032 (Usd Million)
Table 4 U.S. Membranes For Guided Bone/Tissue Regeneration (Gbr/Gtr) In Periodontal Treatment For Adults Market, By Product Type 2018-2032 (Usd Million)
Table 5 U.S. Antibiotics And Antimicrobials In Periodontal Treatment For Adults Market, By Type, 2018-2032 (Usd Million)
Table 6 U.S. Antibiotics And Antimicrobials In Periodontal Treatment For Adults Market, By Route, 2018-2032 (Usd Million)
Table 7 U.S. Oral Antibiotics In Periodontal Treatment For Adults Market, By Type, 2018-2032 (Usd Million)
Table 8 U.S. Topical Antibiotics In Periodontal Treatment For Adults Market, By Type, 2018-2032 (Usd Million)
Table 9 Table 1 U.S. Periodontal Treatment For Adults Market, By Practice Type, 2018-2032 (Usd Million)
Table 10 U.S. Private Practice In Periodontal Treatment For Adults Market, By Product Type, 2018-2032 (Usd Million)
Table 11 U.S. Regenerative Biomaterials In Periodontal Treatment For Adults Market, By Product Type, 2018-2032 (Usd Million)
Table 12 U.S. Bone Grafts In Periodontal Treatment For Adults Market, By Product Type, 2018-2032 (Usd Million)
Table 13 U.S. Membranes For Guided Bone/Tissue Regeneration (Gbr/Gtr) In Periodontal Treatment For Adults Market, By Product Type, 2018-2032 (Usd Million)
Table 14 U.S. Antibiotics And Antimicrobials In Periodontal Treatment For Adults Market, By Type, 2018-2032 (Usd Million)
Table 15 U.S. Antibiotics And Antimicrobials In Periodontal Treatment For Adults Market, By Route, 2018-2032 (Usd Million)
Table 16 U.S. Oral Antibiotics In Periodontal Treatment For Adults Market, By Type, 2018-2032 (Usd Million)
Table 17 U.S. Topical Antibiotics In Periodontal Treatment For Adults Market, By Type, 2018-2032 (Usd Million)
Table 18 U.S. Dso (Dental Service Organizations) In Periodontal Treatment For Adults Market, By Product Type, 2018-2032 (Usd Million)
Table 19 U.S. Regenerative Biomaterials In Periodontal Treatment For Adults Market, By Product Type, 2018-2032 (Usd Million)
Table 20 U.S. Bone Grafts In Periodontal Treatment For Adults Market, By Product Type, 2018-2032 (Usd Million)
Table 21 U.S. Membranes For Guided Bone/Tissue Regeneration (Gbr/Gtr) In Periodontal Treatment For Adults Market, By Product Type, 2018-2032 (Usd Million)
Table 22 U.S. Antibiotics And Antimicrobials In Periodontal Treatment For Adults Market, By Type, 2018-2032 (Usd Million)
Table 23 U.S. Antibiotics And Antimicrobials In Periodontal Treatment For Adults Market, By Route,2018-2032 (Usd Million)
Table 24 U.S. Oral Antibiotics In Periodontal Treatment For Adults Market, By Type, 2018-2032 (Usd Million)
Table 25 U.S. Topical Antibiotics In Periodontal Treatment For Adults Market, By Type, 2018-2032 (Usd Million)
Table 26 U.S. Periodontal Treatment For Adults Market, By Disease Type, 2018-2032 (Usd Million)
List of Figures
Figure 1 U.S. Periodontal Treatment For Adults Market: Segmentation
Figure 2 U.S. Periodontal Treatment For Adults Market: Geographical Scope
Figure 3 U.S. Periodontal Treatment For Adults Market: Years Considered For The Study
Figure 4 U.S. Periodontal Treatment For Adults Market: Data Triangulation
Figure 5 U.S. Periodontal Treatment For Adults Market: Droc Analysis
Figure 6 U.S. Periodontal Treatment For Adults Market: Global Vs Regional Market Analysis
Figure 7 U.S. Periodontal Treatment For Adults Market: Company Research Analysis
Figure 8 U.S. Periodontal Treatment For Adults Market: Interview Demographics
Figure 9 U.S. Periodontal Treatment For Adults Market: Multivariate Modelling
Figure 10 U.S. Periodontal Treatment For Adults Market: Dbmr Market Position Grid
Figure 11 U.S. Periodontal Treatment For Adults Market: Vendor Share Analysis
Figure 12 U.S. Periodontal Treatment For Adults Market: Segmentation
Figure 13 Two Segments Comprise The Us Periodontal Treatment For Adults Market, By Product Type
Figure 14 Us Periodontal Treatment For Adults Market Executive Summary
Figure 15 Rising Prevalence Of Chronic Diseases Is Driving The Growth Of The U.S. Periodontal Treatment For Adults Market From 2025 To 2032
Figure 16 The Cataract Surgery Segment Is Expected To Account For The Largest Share Of The U.S. Periodontal Treatment For Adults Market In 2025 And 2032
Figure 17 Market Overview
Figure 18 U.S. Periodontal Treatment For Adults Market: By Product Type,2024
Figure 19 U.S. Periodontal Treatment For Adults Market: By Product Type, 2025-2032 (Usd Million)
Figure 20 U.S. Periodontal Treatment For Adults Market: By Product Type, Cagr (2025-2032)
Figure 21 U.S. Periodontal Treatment For Adults Market: By Product Type, Lifeline Curve
Figure 22 U.S. Periodontal Treatment For Adults Market: By Practice Type,2024
Figure 23 U.S. Periodontal Treatment For Adults Market: By Practice Type, 2025-2032 (Usd Million)
Figure 24 U.S. Periodontal Treatment For Adults Market: By Practice Type, Cagr (2025-2032)
Figure 25 U.S. Periodontal Treatment For Adults Market: By Practice Type, Lifeline Curve
Figure 26 U.S. Periodontal Treatment For Adults Market: By Disease Type, 2024
Figure 27 U.S. Periodontal Treatment For Adults Market: By Disease Type, 2025-2032 (Usd Million)
Figure 28 U.S. Periodontal Treatment For Adults Market: By Disease Type, Cagr (2025-2032)
Figure 29 U.S. Periodontal Treatment For Adults Market: By Disease Type, Lifeline Curve
Figure 30 U.S. Periodontal Treatment For Adults Market: Company Share 2022 (%) 69
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.